Attralus
Biotechnology ResearchView the employees at
Attralus-
Salome Philip CMC Project Management
-
Santa Monica, California, United States
-
Rising Star
Amy Rocca Operations-
Burlingame, California, United States
-
Rising Star
Molly Schneider Quality Assurance Professional-
Denver Metropolitan Area
-
Top 10%
Dave Conroy Head of Program Management at Attralus-
Nashville Metropolitan Area
-
Rising Star
Stephanie Beighley Communicator, Technology Advocate, Problem Solver-
Allamuchy, New Jersey, United States
-
Rising Star
Overview
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.
-